The differential effects of ZFX silencing on CML CD34+ cells versus NBM CD34+ cells were more pronounced, when a proliferation assay in liquid culture was conducted (Additional file 1: Fig. S3). Here, CD34 is linked to chronic myelogenous leukemia, BCR-ABL1 positive.